WS02.05 Obstetric and neonatal outcomes in cystic fibrosis (CF) show minimal variability with and without elexacaftor/tezacaftor/ivacaftor (ETI)
| Autor: | Downes, A., Flynn, F., Robinson, R., Banya, W., Singh, N., Collins, S., Bowman, E., Belkarty, B., Jones, A., Simmonds, N., Ukor, E., Madge, S., Scott, R., Felton, I. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis June 2023 22 Supplement 2:S5-S5 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect